179 related articles for article (PubMed ID: 16037304)
1. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.
Figarola JL; Scott S; Loera S; Xi B; Synold T; Rahbar S
Ann N Y Acad Sci; 2005 Jun; 1043():767-76. PubMed ID: 16037304
[TBL] [Abstract][Full Text] [Related]
2. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.
Figarola JL; Scott S; Loera S; Xi B; Synold T; Weiss L; Rahbar S
Diabetes Metab Res Rev; 2005; 21(6):533-44. PubMed ID: 15818713
[TBL] [Abstract][Full Text] [Related]
3. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.
Degenhardt TP; Alderson NL; Arrington DD; Beattie RJ; Basgen JM; Steffes MW; Thorpe SR; Baynes JW
Kidney Int; 2002 Mar; 61(3):939-50. PubMed ID: 11849448
[TBL] [Abstract][Full Text] [Related]
4. Novel inhibitors of glycation and AGE formation.
Rahbar S
Cell Biochem Biophys; 2007; 48(2-3):147-57. PubMed ID: 17709884
[TBL] [Abstract][Full Text] [Related]
5. Effect of green tea extract on advanced glycation and cross-linking of tail tendon collagen in streptozotocin induced diabetic rats.
Babu PV; Sabitha KE; Shyamaladevi CS
Food Chem Toxicol; 2008 Jan; 46(1):280-5. PubMed ID: 17884275
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of green tea extract on advanced glycation and cross-linking of collagen in the aorta of streptozotocin diabetic rats.
Babu PV; Sabitha KE; Shyamaladevi CS
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):351-7. PubMed ID: 16620300
[TBL] [Abstract][Full Text] [Related]
7. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.
Karachalias N; Babaei-Jadidi R; Kupich C; Ahmed N; Thornalley PJ
Ann N Y Acad Sci; 2005 Jun; 1043():777-83. PubMed ID: 16037305
[TBL] [Abstract][Full Text] [Related]
8. Chemical modification of muscle protein in diabetes.
Alt N; Carson JA; Alderson NL; Wang Y; Nagai R; Henle T; Thorpe SR; Baynes JW
Arch Biochem Biophys; 2004 May; 425(2):200-6. PubMed ID: 15111128
[TBL] [Abstract][Full Text] [Related]
9. Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats.
Oturai PS; Christensen M; Rolin B; Pedersen KE; Mortensen SB; Boel E
Metabolism; 2000 Aug; 49(8):996-1000. PubMed ID: 10954016
[TBL] [Abstract][Full Text] [Related]
10. The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen cross-linking in streptozotocin-induced diabetic rats.
Stefek M; Gajdosik A; Tribulova N; Navarova J; Volkovova K; Weismann P; Gajdosikova A; Drimal J; Mihalova D
Methods Find Exp Clin Pharmacol; 2002 Nov; 24(9):565-71. PubMed ID: 12616702
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
12. Antihyperglycemic activity and inhibition of advanced glycation end product formation by Cuminum cyminum in streptozotocin induced diabetic rats.
Jagtap AG; Patil PB
Food Chem Toxicol; 2010; 48(8-9):2030-6. PubMed ID: 20451573
[TBL] [Abstract][Full Text] [Related]
13. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
Bhatwadekar A; Glenn JV; Figarola JL; Scott S; Gardiner TA; Rahbar S; Stitt AW
Br J Ophthalmol; 2008 Apr; 92(4):545-7. PubMed ID: 18211931
[TBL] [Abstract][Full Text] [Related]
14. Renoprotective effects of a novel inhibitor of advanced glycation.
Forbes JM; Soulis T; Thallas V; Panagiotopoulos S; Long DM; Vasan S; Wagle D; Jerums G; Cooper ME
Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
[TBL] [Abstract][Full Text] [Related]
15. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Food Sci; 2011 Sep; 76(7):H165-74. PubMed ID: 22417553
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy.
Lee SH; Kim YS; Lee SJ; Lee BC
J Ethnopharmacol; 2011 Oct; 137(3):1409-14. PubMed ID: 21856399
[TBL] [Abstract][Full Text] [Related]
17. Pyridoxal phosphate prevents progression of diabetic nephropathy.
Nakamura S; Li H; Adijiang A; Pischetsrieder M; Niwa T
Nephrol Dial Transplant; 2007 Aug; 22(8):2165-74. PubMed ID: 17449494
[TBL] [Abstract][Full Text] [Related]
18. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.
Figarola JL; Scott S; Loera S; Tessler C; Chu P; Weiss L; Hardy J; Rahbar S
Diabetologia; 2003 Aug; 46(8):1140-52. PubMed ID: 12845431
[TBL] [Abstract][Full Text] [Related]
19. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats.
Kim HY; Okamoto T; Yokozawa T
J Ethnopharmacol; 2009 Jul; 124(2):263-9. PubMed ID: 19397970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
